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and Jaap van Weeghel2,7,8
Abstract
Background: People with Severe Mental Illness (SMI) frequently experience problems with regard to societal
participation (i.e. work, education and daily activities outside the home), and require professional support in this area.
The Boston University approach to Psychiatric Rehabilitation (BPR) is a comprehensive methodology that can offer
this type of support. To date, several Randomised Controlled Trials (RCT’s) investigating the effectiveness of BPR have
yielded positive outcomes with regard to societal participation. However, information about the cost-effectiveness and
budgetary impact of the methodology, which may be important for broader dissemination of the approach, is lacking.
BPR may be more cost effective than Care As Usual (CAU) because an increase in participation and independence
may reduce the costs to society. Therefore, the aim of this study is to investigate, from a societal perspective, the
cost-effectiveness of BPR for people with SMI who wish to increase their societal participation. In addition, the budget
impact of implementing BPR in the Dutch healthcare setting will be assessed by means of a budget impact analysis
(BIA) after completion of the trial.
Methods: In a multisite RCT, 225 adults (18–64 years of age) with SMI will be randomly allocated to the experimental
(BPR) or the control condition (CAU). Additionally, a pilot study will be conducted with a group of 25 patients with
severe and enduring eating disorders. All participants will be offered support aimed at personal rehabilitation goals,
and will be monitored over a period of a year. Outcomes will be measured at baseline, and at 6 and 12 months after
enrolment. Based on trial results, further analyses will be performed to assess cost-effectiveness and the budgetary
impact of implementation scenarios.
Discussion: The trial results will provide insight into the cost-effectiveness of BPR in supporting people with SMI who
would like to increase their level of societal participation. These results can be used to make decisions about further
implementation of the method. Also, assessing budgetary impact will facilitate policymaking. The large sample size,
geographic coverage and heterogeneity of the study group will ensure reliable generalisation of the study results.
Trial registration: Current Controlled Trials: ISRCTN88987322. Registered 13 May 2014.
* Correspondence: s.sanches@altrecht.nl
1Altrecht Mental Health Care, Lange Nieuwstraat 119, 3512 PG, Utrecht, The
Netherlands
2Tranzo Scientific Center for Care and Welfare, Tilburg University, Tilburg
School of Social and Behavioral Sciences, PO Box 90153, 5000 LE, Tilburg, The
Netherlands
Full list of author information is available at the end of the article
© 2015 Sanches et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sanches et al. BMC Psychiatry  (2015) 15:217 
DOI 10.1186/s12888-015-0593-8
Background
High unemployment rates and general difficulty in
undertaking activities are common among people with
Severe Mental Illness (SMI) around the world [1–11].
The needs of these people comprise access to a broad
array of services, which are not limited to clinical and
humanitarian needs, but also include rehabilitation re-
quirements such as support with societal participation,
which is defined as engaging in meaningful daily ac-
tivities [12, 13].
Meaningful daily activities can be described as activities
that fulfil a goal or purpose that is personally and/or cul-
turally important, and are positively correlated with qual-
ity of life [14–16]. An example of such an activity is
regular employment, which is associated with higher self-
esteem, fewer psychiatric symptoms, general wellbeing
and higher quality of life [17–19]. When it comes to
engaging in meaningful daily activities, people with SMI
experience environmental obstacles such as lack of oppor-
tunities and support or negative images of the clients’ po-
tential on the part of possible employers and others in
their environments. They also have to cope with personal
obstacles such as self-stigmatisation, psychiatric symptoms
and lack of social skills, employment skills and emotional
stability. A combination of these barriers, which often
reinforce each other, can lead to motivational problems
and fear of failure [20]. As a result, more people with SMI
are unemployed and undertake fewer activities outside the
home than may be explained by the seriousness of their
psychiatric symptoms. Support in the area of societal par-
ticipation is therefore vital.
Over the years, various methods have been developed to
offer support in engaging in work and other meaningful
activities. However, only a few of these have been proven
effective. An example of a well-documented, evidence-
based approach to supporting the employment needs of
patients with SMI is the Individual Placement and Sup-
port model of supported employment (IPS) [21–23].
Whereas IPS focuses mainly on regular paid em-
ployment, the Boston University approach to Psychiatric
Rehabilitation (BPR) has a broader scope and also fo-
cuses on other forms of meaningful activities, housing,
education, social contacts, and of course, work (regular
and sheltered employment as well as voluntary work).
The mission of BPR is to “help persons with psychiatric
disabilities increase their ability to function successfully
and be satisfied in the environment of their choice with the
least amount of ongoing professional intervention” [24].
In recent years, a number of RCTs have been performed
which investigate the effectiveness of BPR and results are
partially positive. In the United States, Rogers et al. [25]
investigated the effectiveness of Psychiatric Vocational re-
habilitation (BPR in the vocational context) but found no
differences in vocational or clinical outcomes compared to
a control condition. However, the researchers made con-
siderable enhancements to the control condition, which
may have diminished the contrast between the experimen-
tal and control condition. Positive results were found by
Shern et al. [26], also in the United States, who focused on
street-dwelling individuals with psychiatric disabilities.
They found that the experimental group experienced
fewer psychiatric symptoms and a better quality of life
than the control group. Also, the experimental group
spent significantly less time on the streets and showed
increased societal participation in terms of a greater likeli-
hood to attend a day programme than the control group.
In Italy, Gigantesco et al. [27] investigated a specific
structured planning and evaluation approach called
VADO (in English, Skills Assessment and Definition of
Goals) which is inspired by BPR. They found greater
improvement in the personal and social functioning in
patients treated with VADO compared to routine care.
Swildens et al. [9] performed a multisite RCT in the
Netherlands with 156 SMI patients in outpatient MHC,
sheltered living and inpatient rehabilitation units. This
study covered all rehabilitation areas: work, education,
structured activities, social contacts and living independ-
ently. Patients were randomised to BPR or Care As Usual
(CAU) with follow-ups after 12 and 24 months. The rate
of goal attainment was substantially higher in BPR at 12
and 24 months than with CAU. Also, BPR was more ef-
fective with regard to promoting social contacts and soci-
etal participation. However, both groups improved equally
with regard to quality of life, and BPR was no more suc-
cessful than CAU with regard to living independently.
Despite the positive results and the subsequent rec-
ommendation of BPR in the Dutch Guidelines for
Schizophrenia [28], implementation in MHC practice is
still limited. The lack of insight into the cost-effectiveness
structure of BPR is one of the obstacles to implementa-
tion. For instance, BPR may be more intensive than CAU
and require an initial time investment from caregivers,
which could later be compensated by increased indepen-
dency and the empowerment of the patient. Indeed, if
BPR effectively improves the societal participation of pa-
tients with SMI according to their own wishes, and pa-
tients have fewer needs, this may promote long-term
improvement in functioning and have a positive effect on
costs for society. A cost-effectiveness study is required to
provide answers to these and other cost-related matters,
and the results –if positive- may lead to broader dissemin-
ation of the approach. Therefore, in this study we aim to
analyse the cost-effectiveness of BPR compared to CAU
from a societal perspective. To further support policy-
making regarding implementation, the trial results will be
used in different implementation scenarios to assess the
budget impact of implementing BPR in the Dutch health-
care setting.
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Objectives/aims
The main objective of the research is to gain insight into
the effectiveness and cost-effectiveness of the Boston Univer-
sity approach to Psychiatric Rehabilitation (BPR) compared
to Care as Usual (CAU) for patients with SMI (aged 18–
64 years) who wish to increase their societal participation.
The primary outcome criterion is change in societal
participation, which is defined as the presence of mean-
ingful activities: paid work, regular voluntary work, vo-
cational training or academic study, or full-time care of
a family [9]. Secondary outcome measures are: patients’
experience of success, quality of life, psychosocial func-
tioning, recovery, self-efficacy, health status and realising
patients’ personal rehabilitation goals. Furthermore, we
will conduct a budget impact analysis (BIA) to estimate
the consequences of the broader implementation of BPR
in the Dutch healthcare system.
The main research question is:
 Is BPR effective as well as cost-effective with regard
to societal participation compared to CAU after
12 months for patients with SMI between the ages
of 18 and 64 who have a wish for change in this
rehabilitation area?
Secondary research questions are:
 Is BPR an effective intervention with regard to
societal participation, in terms of patients’
experience of success, quality of life, psychosocial
functioning, recovery, self-efficacy, health status and
realising patients’ personal rehabilitation goals after
6 and 12 months for our target group?
 What are the financial consequences of broader
implementation of BPR in the Dutch healthcare system?
Methods
Study design
A multicentre two parallel arm Randomised Controlled
Trial (RCT) with repeated measures will be used to
compare the cost-effectiveness of BPR with CAU in im-
proving societal participation.
CAU encompasses various approaches commonly used
to support patients with SMI. These include generic pro-
grammes for mental health nursing care, social work
and vocational rehabilitation. CAU is provided by mul-
tidisciplinary MHC teams with assertive outreach ele-
ments for patients who need more intensive contact
(Flexible ACT teams) and by Dutch regional institutes
for Residential Care (RIRC, Dutch acronym RIBW),
which support independent living in the community and
offer supported housing facilities [29–32].
Participants will be randomly allocated to either the
experimental group or the control group. Outcomes will
be assessed at baseline, 6 and 12 months. Based on main
study results as well as dropout rate and degree of ad-
herence, scenarios for implementation will be formu-
lated and assessed for their budgetary impact. An
overview of the study design is shown in Fig. 1.
Participating centres/setting
The study will be conducted at two regional MHC centres
and a Dutch regional centre for Residential Care. In
addition, a specialist team for SMI patients with long and
enduring eating disorders will participate in the study.
Participants
The study will include a heterogeneous group of 225
adult outpatients with SMI who express a wish to in-
crease their societal participation. SMI is characterised
by psychiatric disorders with a long duration of treat-
ment and severe dysfunction. In the Netherlands, ap-
proximately 160,000 patients between 18 and 65 suffer
from SMI [33]. Although most patients in this group
have a history of psychosis, the definition of severe dys-
function is not limited to those with psychotic disorders
[34]. Some patients have multiple diagnoses such as
varying combinations of psychotic disorders, bipolar
disorder, anxiety disorders, personality disorders, eating
disorders and drug addiction. All patients are care recip-
ients of the participating organisation that supports in-
dependent living in the community and offers supported
housing facilities, or of FACT teams [35] at the par-
ticipating regional mental health care (MHC) centres. A
pilot group of 25 patients with severe and enduring eat-
ing disorders –often in combination with other severe
psychiatric diagnoses- will be included in the study to
add insight into the effectiveness of BPR for this group
of long-term mentally ill patients. Patients with eating
disorders also face problems such as entering or re-
entering the labour market and/or finding meaningful
ways of spending the day. These patients are often hos-
pitalised for extreme underweight, meaning that this
group will consist of outpatients as well as inpatients.
MH professionals will assess eligibility for participation
in the study according to the following inclusion and ex-
clusion criteria:
Inclusion criteria
Patients are eligible for participation if they:
a) Have been diagnosed with Severe Mental Illness
(a diagnosis according to DSM IV, long duration of
service contact and functional impairment which
substantially interferes with or limits one or more
major life activities [36]) and/or have a severe and
enduring history of Anorexia Nervosa.
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b) Have expressed a wish for change in societal
participation (work, education, daily activities
outside the home).
c) Are between 18 and 64 years of age.1
d) Are willing to participate in the study.
Exclusion criteria
Patients will be excluded if they:
a) Have received BPR in the four months preceding the
start of the trial.
e) Are admitted as inpatients to a MHC centre at the
start of the study (except for patients with Anorexia
Nervosa).2
b) Are legally incompetent.
Interventions
Experimental group: Boston Psychiatric Rehabilitation (BPR)
Patients in the experimental group will take part in
rehabilitation sessions based on BPR, which uses a
methodology that helps patients achieve and retain their
Fig. 1 Consort diagram. Abbreviations: C1 - Centre1, C2 - Centre2, C3 - Centre3, CED – Centre for Eating Disorders, BPR – Boston Psychiatric
Rehabilitation, CAU – Care As Usual
Sanches et al. BMC Psychiatry  (2015) 15:217 Page 4 of 13
rehabilitation goals [24, 37, 38]. The approach consists
of four phases:
a) Exploring: the client is supported in discovering
what he/she wants to achieve.
b) Choosing: the client is supported in choosing a goal
in a rehabilitation area such as work or housing.
c) Getting: the client is supported in carrying out the
necessary interventions to attain the goal.
d) Keeping: the client is supported in keeping the
attained goal.
Patients do not need to have a clearly defined idea or
plan for change in order to receive BPR because an im-
portant component of BPR is helping patients explore
their options. Therefore, BPR attends to the needs of pa-
tients who have been suffering from mental illness for a
long time and have lost confidence in their own ability to
initiate change. Participants assigned to BPR will be of-
fered at least one session every 2 weeks with an experi-
enced BPR rehabilitation worker. There is no predefined
maximum or minimum number of sessions that must be
completed. Instead, patient and BPR worker plan sessions
by agreement. However, BPR workers are obliged to offer
one session every 2 weeks. The total number of sessions
and duration of the period in which patient and worker
cooperate will be registered. The intervention will be car-
ried out by rehabilitation workers fully trained in the
methodology (social workers, MH nurses, occupational
and vocational therapists) who have practised with at least
four patients under the supervision of a certified expert in
BPR. Each participating centre will take part by involving
at least four workers experienced in BPR in the BPR con-
dition. Each worker will have an additional caseload of
four research patients a year. In all three centres, a suffi-
cient number of professionals with BPR training are avail-
able to carry out the intervention.
Fidelity in the experimental condition will be checked by
means of a BPR fidelity measure, using criteria developed
by the Dutch foundation for BPR ‘Stichting Rehabilitatie
‘92’ in collaboration with the Boston University Center for
Psychiatric Rehabilitation. Independent registered BPR ex-
perts will use the instrument to blindly rate all patient
treatment files involved in this study. Furthermore, BPR
workers will receive regular feedback and supervision.
Control group: Care As Usual (CAU)
Patients in the control group will receive CAU conducted
according to the guidelines for FACT teams [29, 35, 39, 40]
and Dutch RIRCs [31]. These guidelines form a general
outline of the philosophy of care for the target groups and
the way care is delivered in daily practice. The FACT
model, which was developed in The Netherlands [35],
contains all elements of the internationally well-known
Assertive Community Treatment (ACT) model [41], but
FACT differs from ACT in that a FACT team also targets
patients who function in a more or less stable manner.
These multidisciplinary teams provide medical, psychiatric,
social, financial and vocational support, which can be in-
tensified according to the patients’ needs. Detailed infor-
mation about the Dutch FACT model is described in the
English version of the FACT Manual [42].
In the Netherlands, supported housing and supported
independent living in the community for patients with
SMI is provided by 21 RIRCs. RIRC’s are primarily con-
cerned with patient’s daily activities but also offer some
support with regard to participation in society [30, 32].
However, structural support with rehabilitation is often
lacking.
In line with the experimental group, participants as-
signed to the control group will also be offered at least
one session every 2 weeks targeting a wish for societal
participation, with no predefined maximum or minimum
number of sessions that must be completed. Patient and
CAU worker plan sessions by agreement and the total
number of sessions and duration of their cooperation
will be registered.
Although MH professionals working according to FACT
or RIRC guidelines (social workers, MH nurses, oc-
cupational therapists or employment specialists) may be
familiar with rehabilitation, they have not received specific
training in BPR. They offer additional support to patients
in clarifying and achieving their rehabilitation goals on the
basis of generic MHC models: mental health nursing care,
social work and vocational rehabilitation programmes. All
CAU workers have at least 1 year of experience with sup-
porting SMI patients. Each participating centre will pro-
vide at least three experienced rehabilitation workers to
the CAU condition and each worker will have an add-
itional caseload of at most 4 to 5 research patients a year.
In all three centres, a sufficient number of professionals
without BPR training are available to carry out the inter-
vention. Because of the generic nature of CAU, fidelity will
not be measured in this condition. However, CAU workers
will receive regular supervision according to the FACT
and RIRC guidelines to ensure a high level of care.
Contamination between BPR and CAU
Because workers from BPR and CAU conditions work in
the same team environment and come in contact with each
other, some contamination between conditions is unavoid-
able. However, BPR is a complex method that cannot be
properly applied without extensive training and ongoing
methodological supervision. Moreover, our focus is on the
possible added value of specific rehabilitation techniques
and not solely on rehabilitation attitude, for example. We
therefore believe that the contrast between conditions will
be great enough to detect possible differences.
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Measures
All measures and related domains are summarised in
Table 1. All instruments have been designed to be sensi-
tive enough to measure change in patients with SMI. A
mixture of self-reporting instruments and assessment by
MH professionals is used, which is generally recom-
mended for research with SMI patients [43].
Primary outcome measures
1. The first primary outcome measure will be societal
participation in the past 6 months. This is expressed
in paid work, voluntary work and schooling (yes/no).
This measure will be derived from the subscale
Employment/Occupation of the self-report
Birchwood Social Functioning Scale (SFS) [44]
using a hierarchical index to dichotomise whether
or not there is an increase in societal participation
at 6 and/or 12 months. The SFS was constructed
to measure areas of functioning that are crucial
for the community maintenance of people with
schizophrenia (i.e. psychosocial functioning).
The SFS focuses on fundamental characteristics
of societal functioning and consists of seven
subscales:
1) Social engagement/withdrawal, 2) Interpersonal
behaviour, 3) Pro-social activities, 4) Recreation, 5) Inde-
pendence-competence, 6) Independence-performance, 7)
Employment/occupation.
The SFS proved a reliable and valid instrument for meas-
uring psychosocial functioning with a high level of internal
consistency (Full scale α = 0, 80, Factor loadings >0, 70).
2. The second primary outcome is current level of
societal participation, which will be measured using
the Dutch National Societal Participation Ladder
[45]. The Dutch National Societal Participation
Ladder was developed for the Social Support Act
(Dutch: WMO) and establishes the level of societal
participation in six steps:
1 = severe social isolation, 2 = social contacts outside the
home, 3 = participation in organised activities, 4 = having an
unpaid job, 5 = having a paid job with support, 6 = having
a paid job.
A flowchart is used to determine the right step. The
bottom two steps are considered a low level of societal
participation. The instrument was developed for use by
local governments throughout the Netherlands and
was implemented in 2008. In 2013, the instrument was
used by 73 % of social services [46]. Findings from a
pilot study in 2009 [45] and an evaluation study in
2011 [47], indicated that the definitions of the steps
are good, the instrument leaves little scope for per-
sonal interpretation and is short, clear and easy to
work with. The Dutch National Societal Participation
Ladder will be further validated with the subscale
Employment/Occupation of the self-report Birchwood
Social Functioning Scale (SFS) [44].
3. The final primary outcome measure is total hours
of societal participation. This will be derived from
the self-report Birchwood Social Functioning Scale
(SFS) [44] and from a detailed questionnaire
regarding Medical and Non-Medical costs based
in part on the Tic-P by Hakkaart et al. [48]
(see ‘Medical Costs’ for more information).
Table 1 Overview of outcome and other measures
Domain Measurement
Primary outcome measures
Societal participation in the past
6 months
Subscale Employment/Occupation
of the Birchwood Social
Functioning Scale




Total hours of societal
participation







Birchwood Social Functioning Scale
Patients’ psychosocial
functioning from the MHC
team’s perspective
Activity and Participation Scale
Patients’ experience of goal
attainment (yes/no)
Structured interview
Quality of Life Manchester Quality of Life
Schedule
Recovery Recovery Assessment Scale
Self-efficacy General Self Efficacy Scale
Cost-effectiveness outcome
measures
Generic health Status 12-item Short Form





Brief Psychiatric Rating Scale
Overall level of psychological,
social and occupational
functioning
Global Assessment of Functioning,
Symptoms and Disabilities version
Quality of the therapeutic
relationship
Helping Alliance Scale
Intervention uptake Drop-out and non-adherence
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Secondary outcome measures
Secondary outcome measures will be:
1. Patients’ psychosocial functioning from their own
perspective is measured by the Birchwood Social
Functioning Scale (for psychometric information see
primary outcome measures) [44].
2. Patients’ psychosocial functioning from the MHC
team’s perspective is measured with the Activity and
Participation Scale (perspective of MH professional)
[49]. The Activity and Participation Scale captures
the level of participation and activity on seven
dimensions:
1) Internal social integration, 2) Basal independence, 3)
Use of Media, 4) Contacts with persons outside the MHC
centre/living community without leaving the centre
grounds.
5) Leaving the centre grounds, 6) Potential social
skills, 7) Hostility to others.
The Activity and Participation Scale can be used with
outpatients as well as inpatients and has good psycho-
metric properties (α = 0.88). Factor analysis showed one
factor: ‘Level of activities and participation’.
3. Patients’ subjective experience of goal attainment
(yes/no) in achieving societal participation goals in
the areas addressed, such as work and schooling. For
this purpose we use a structured interview devised
for previous studies [9, 50, 51].
4. Quality of life is measured by the Manchester
Quality of life Schedule/MANSA [52]. The
MANSA is specifically constructed to measure
quality of life in patients with psychiatric problems
and focuses on satisfaction with life as a whole.
The MANSA has been translated into Dutch by
Van Nieuwenhuizen et al. [53]. Twelve subjective
items are answered on a 7-point Likert scale
ranging from 1 = couldn’t be worse to 7 = couldn’t
be better and four objective items are answered
with yes/no. MANSA shows adequate internal
consistency (α = 0.74; [41], α = 0.81; [54]) and is
highly correlated with satisfaction ratings on
the Lancashire Quality of Life Profile (LQLP:
r = > 0.82; [52]).
5. Recovery is measured with the Recovery Assessment
Scale [55]. The Recovery Assessment Scale (RAS) is
constructed to measure recovery from serious
psychiatric illnesses. The RAS consists of a grand
score and five separate factors:
1) Personal confidence and hope, 2) Willingness to ask
for help, 3) Goal and success orientation, 4) Reliance on
others, 5) No domination by symptoms.
RAS has 41 items and is answered on a 5-point Likert
Scale ranging from 1 = strongly disagree to 7 = strongly
agree. Psychometric properties have been investigated
by Corrigan [55]. Cronbach’s alpha for the five factors
ranges from 0.74 to 0.87. Convergent validity for the
five factors ranges from moderate (R2 = 27.7 %) to fairly
high (R2 = 68.9 %).
6. Self-efficacy is measured with the General Self
Efficacy Scale (GSES) [56]. This scale consists of 10
items to measure Self-efficacy on a 4-point Likert
Scale ranging from 1 = not at all true to 4 = exactly
true. Perceived self-efficacy is the belief in one’s
competence to tackle difficult or novel tasks and to
cope with adversity in specific demanding situations.
The GSES has good psychometric properties:
Cronbach’s alpha ranges from 0.79 to 0.90 in
various study samples and self-efficacy is positively
correlated with Quality of Life [57].
The following secondary outcome measures are specif-
ically used for the cost effectiveness study.
7. Generic health status is measured with the 12-item
Short Form Health Survey (SF-12) [58]. The SF-12
is a short and efficient instrument to measure
functional health and wellbeing from the patient’s
point of view. In particular, the subjective evaluation
of one’s physical, psychological and social functioning.
It is a shortened version of the well-known SF-36 and
covers the same 8 dimensions, with one or two
questions per domain:
1) Physical functioning, 2) Role-Physical, 3) Bodily Pain,
4) General Health, 5) Vitality, 6) Social Functioning,
7) Role-Emotional, 8) Mental Health.
In our study, we will use the 4-week recall version.
SF-12 shows good test-retest reliability with coeffi-
cients ranging from 0.76 to 0.89 [59]. Also, validity is
good with Relative validity coefficients (RV) ranging
from 0.63 to 0.92. Gandek et al. [60] tested the psy-
chometric properties of SF-12 in nine European coun-
tries and found substantial correlations between the
summary measures scored from SF-36 and SF-12
Health Surveys. Also, Jenkinson [61] found SF-12 to
have the same capability of measuring change in
health status over time as the SF-36. We will use the
methodology developed by Brazier and Roberts [62] to
estimate preferences for health states based on specific
items (often referred to as the SF6D) from the admin-
istered SF12. These preferences will subsequently be
used to derive Quality Adjusted Life-Years (QALYs),
which is a commonly used outcome in economic eval-
uations [63].
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8. Medical costs will include costs of the interventions
(BPR and CAU), inpatient and outpatient mental
health care, general health care, costs of day activity
institutions and medication use. Healthcare
consumption will be registered with a detailed
questionnaire administered to the respondents at
each of the measurements. This questionnaire was
adapted to the specific context of the current study,
and partially based on the Tic-P by Hakkaart et al.
[48]. Unit prices will largely be based on Dutch
standard prices in order to facilitate comparisons
with other economic evaluations [64]. Apart from
medical costs, non-medical costs will be assessed
as well.
9. Non-medical costs will be assessed with the same
questionnaire, especially costs of informal care and
costs related to productivity losses.
Other measures
The following measures include data on possible con-
founding and/or mediating variables.
1. Sociodemographic information will be gathered by
means of a structured interview scheme at the start
of the study and checks will be performed in the
interviews that follow at 6 and 12 months.
2. Psychiatric symptoms and remission are measured
with the Brief Psychiatric Rating Scale [65–67] in
order to control for large changes in symptomatic
functioning. The BPRS was developed as a quick and
efficient method to describe and evaluate change in
psychiatric symptoms. We use the 24-item version
which measures the following symptoms: 1) Somatic
concern, 2) Anxiety, 3) Depression, 4) Suicidality,
5) Guilt, 6) Hostility, 7) Elevated Mood, 8) Grandiosity,
9) Suspiciousness, 10) Hallucinations, 11) Unusual
thought content, 12) Bizarre behaviour, 13) Self-neglect,
14) Disorientation, 15) Conceptual disorganisation,
16) Blunted affect, 17) Emotional withdrawal, 18)
Motor retardation, 19) Tension, 20) Uncooperativeness,
21) Excitement, 22) Distractibility, 23) Motor
hyperactivity, 24) Mannerisms and posturing. Items
are answered on a 7-point Likert Scale. Every scoring
option has a short description of behaviours that
must be observed for that particular score. The
psychometric properties of the BPRS have often been
investigated and BPRS has proven to be a reliable and
valid instrument [68, 69]. Internal consistency is good
with alphas >0.70.
3. Overall level of psychological, social and
occupational functioning is measured with the
Global Assessment of Functioning (GAF), symptoms
and disabilities version (GAF-SD) [70]. GAF is
scored on a scale ranging from 0 to 100 with higher
scores reflecting fewer symptoms (GAF-S) and
handicaps (GAF-D). The GAF-SD has proven to
be a reliable and valid measure of psychiatric
disturbance in a sample of people with SMI.
4. Quality of the therapeutic relationship is measured
with the Helping Alliance Scale (HAS) [71]. The
HAS was originally developed to measure the quality
of the therapeutic relationship from the client’s
point of view but an adapted version for the
professional’s point of view also exists. Both versions
consist of five items concerning the therapeutic
relationship. Items are scored on an 11-point
visual analogue scale ranging from 0 = not at all to
10 = entirely, with marked 10 mm intervals.
Additionally, the client version has a sixth item
asking about how patients feel immediately after
seeing their MH professional which is answered with
unchanged, better or worse. The professional version
has two additional open items that ask about
positive and negative aspects of the therapeutic
relationship. So far, the HAS has not been
psychometrically evaluated but has been used in
several studies investigating the therapeutic
relationship [71–73].
5. Uptake of the intervention will be assessed by
gathering detailed information about drop-out and
non-adherence during the trial.
Sample size
With regard to the main outcome measure, the power
analysis was based on the earlier finding that the pro-
portion of patients engaged in meaningful activities in-
creased by 11.5 % for BPR compared to 0 % for CAU
after 1 year [9]. With this expected difference in propor-
tion of change in both conditions, the study will have a
power of 80 % (alpha = 0.05, two sided) if complete data
from 2 × 90 patients is obtained. Furthermore, with re-
gard to the economic evaluation, SF-12D is used to cal-
culate a preference-based utility index, SF-6D. In the
preceding RCT, the SF-12D [58] was not used, but
scores on the WHOQOL are available [74]. For patients
with rehabilitation goals in the area of societal participa-
tion, the differences between BPR and CAU after one
year were 1.23 (SD 2.18). Calculating the required power
of the study with this parameter, only 60 patients in each
condition are needed to achieve 80 % power. Power rises
to 95 % with 90 participants in each condition, which is
needed for the primary outcome measure. Taking into
account an average dropout rate of 20 % and a max-
imum dropout rate of 25 % after one year follow up, at
least 225 respondents with SMI are needed for this trial.
The number of patients eligible but not willing to par-
ticipate will be carefully monitored to support the BIA.
A pilot will be conducted for the additional 25 patients
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with severe and persistent eating disorders who will also
participate in this study, since no information is available
on the differences in change that can be expected after a
year with and without BPR support for this group.
Randomisation
After written informed consent has been received, an in-
dependent investigator using a stratified block random-
isation scheme will assign participants to CAU or BPR.
Stratification factors are ‘centre’ and ‘employment in the
preceding year (yes/no)’. The group with eating disor-
ders has an additional stratification factor: ‘duration of
hospitalisation in the 6 months prior to inclusion (less/
more than 3 months)’ because this group in particular
needs support with rehabilitation goals directly after
hospitalisation. In order to avoid large differences be-
tween both conditions in the level of costs during the
period before commencement of the study, duration of
hospitalisation will be added as an extra stratification fac-
tor for this group. Random allocation to either experimen-
tal group or control group will take place immediately
after the baseline measurements have been completed.
Blinding
Patients, MH professionals and research staff cannot be
blinded to the allocated intervention after randomisa-
tion. However, interviewers who gather data will remain
blind to treatment condition. Furthermore, research as-
sistants blinded to treatment allocation will enter data,
and research staff will only perform statistical analyses
on final, anonymous datasets.
Statistical analyses
Primary clinical analyses
The primary analyses will be performed according to the
‘intention to treat’ principle: all patients, including those
who did not initiate or complete a rehabilitation process,
will remain in the group as assigned. Missing items will
be handled according to questionnaire instructions and
standards. Furthermore, data will be collected from mul-
tiple sources (patients and workers), which allows in-
direct judgements to be used as proxies of missing data
if needed.
To analyse results on the main outcome, the difference
in percentage of patients with increased participation in
both groups after 1 year will be compared. Firstly, de-
scriptive statistics will be performed with regard to the
proportions of patients with increased participation.
Secondly, risk differences yielding numbers needed to
treat (NNT) will be calculated using (multilevel) regres-
sion models to be adjusted for research centre and em-
ployment in the year preceding the study. Other possible
confounders such as sociodemographics, psychiatric
symptoms and remission, quality of the therapeutic
relationship or educational level of MH professional will
be added if comparison between intervention group and
control group shows differences between these groups
despite randomisation. In addition, sensitivity analyses
will be performed on all outcomes, including only re-
spondents who participated in at least two contacts with
the rehabilitation worker and excluding patients for
whom the outcome was rated indirectly because they
were not available for interviews at 6 and 12 months.
Secondary outcomes are (I) continuous variables index-
ing quality of life, psychosocial functioning, recovery and
self-efficacy and (II) binary variables indexing patients’
experience of success in achieving their rehabilitation
goals (yes/no). Patients’ experience of success in achieving
their rehabilitation goals could also be presented as an
(III) ordinal variable (yes/no/partially). Means and propor-
tions of these variables at baseline, 6 and 12 months will
be modelled using both multilevel linear and logistic re-
gression analyses in which each person (level 2) con-
tributes three observations (level 1), making adjustments
for participating centre, and other confounders. Treat-
ment effects will be quantified using the Time (baseline, 6
and 12 months) × Group (BPR and CAU) interaction,
assessing whether change in the outcome of interest over
time differs significantly between the two groups.
Effects of time stratified by treatment group will be cal-
culated by linear combination of the appropriate terms
in the model using the General Linear Model (GLM)
procedure in SPSS.
Cost-effectiveness analysis
An economic evaluation will be conducted alongside the
clinical study to assess the cost-effectiveness of BPR
compared to CAU in patients with SMI. The analysis
will be performed from a societal perspective; costs in
and outside the healthcare sector will be included. Time
horizon of the study is 12 months, during which costs
and health outcomes will be prospectively registered for
all patients included. Costs and health outcomes will not
be discounted due to the length of the current time
horizon, which is in line with current guidelines on eco-
nomic evaluations [63]. Univariate and multivariate sen-
sitivity analyses will address important cost aspects, such
as components of the intervention costs and hospitalisa-
tion. Uncertainty surrounding the cost-effectiveness and
cost-utility ratios will be assessed by bootstrap analyses.
In addition, cost-effectiveness acceptability curves will
be used to inform decision-makers on the probability of
the examined intervention being cost-effective.
Societal participation will be used as primary outcome
measure of the cost-effectiveness analysis. Results will be
expressed in terms of incremental costs per proportion
of increase in societal participation gained. This outcome
is highly relevant for patients with a history of SMI, but
Sanches et al. BMC Psychiatry  (2015) 15:217 Page 9 of 13
also closely relates to recent policy decisions on
structural changes in the MHC sector (promoting de-
institutionalisation and community care at lower costs).
Furthermore, a cost-utility analysis will be conducted
with the QALY (Quality Adjusted Life Years) as pri-
mary outcome measure. In order to estimate QALYs,
utility scores will be derived from the SF-6D [62]. The
SF-6D appears to have methodological advantages over
other based instruments in patient populations with –
mainly – psychotic disorders [75].
Budget impact analysis
A budget impact analysis (BIA) will be conducted to
inform decision-makers about the financial conse-
quences of the further implementation of BPR in the
Dutch healthcare system. The BIA will provide insight
into the total financial consequences from a societal
perspective, as well as consequences for individual
stakeholders in the form of an overview of net gains/
costs [76]. The trial results will be extrapolated to a
time horizon of up to four years and to the entire
Dutch patient population concerned using health eco-
nomic modelling. The model will combine the results
of the cost-effectiveness analysis with epidemiological
data on the targeted patient population, as well as
data on programme scale and implementation. The
BIA will require information about the size of the
population of patients with SMI who are eligible and
will participate in the intervention under study. Three
scenarios will be evaluated:
1. A maximum implementation scenario assuming full
participation of all eligible patients.
2. A trial scenario assuming participation rates as
observed in the study.
3. A real world scenario, using larger non-participation,
preferably based on previous experience with the
introduction of FACT.
For all three scenarios, the 12-month results regard-
ing societal participation will be extrapolated to results
over a 48-month time horizon. This requires assump-
tions on how participation at 12 months will be sus-
tained. Since specific data for the current population
are lacking, we plan to use general population data
concerning quit rates from various types of participa-
tion in combination with literature on similar interven-
tions (if available). A distribution will be used to reflect
uncertainty surrounding this parameter. Further mod-
elling assumptions required concern the use of re-
sources during months 12 to 48 and the sustainability
of effects on quality of life. The BIA will be conducted
and reported according to the recently updated guide-
lines of Sullivan et al. [77].
Ethics committee approval
Ethical approval for this study was granted by the
Medical Ethical Committee of the University Medical
Center Groningen (UMCG) on 29 November 2013
(reference number: 2013/70) for all participating sites.
The study is also registered with the Controlled Clinical
Trials registry (ISRCTN88987322).
Time scale
The study will be conducted from August 2013 until
August 2017. Data gathering is planned from February
2014 until February 2017.
Discussion
The aim of this study is to investigate the cost-effectiveness
and budgetary impact of the Boston University approach
to Psychiatric Rehabilitation (BPR) compared to Care
as Usual (CAU) for people with SMI who wish to in-
crease their societal participation. This research is
highly relevant because people with SMI require sup-
port in several rehabilitation areas, in particular em-
ployment and other forms of societal participation. On
average 80 % of the patients with SMI are unemployed
[3–7]. This number is consistent among studies and
also applies to the Dutch situation [8, 9]. Data from a
large panel of Dutch patients with enduring psychiatric
illnesses showed that only 16 % of the panel members
had a regular paid job of 12 hours or more per week,
but more than half of panel members indicated a wish
to undertake more activities outside the home [10, 11].
These facts clearly illustrate a large need for support in
this area, and BPR may be a successful method for pro-
viding this support.
Promoting participation in mainstream activities in the
community is increasingly seen as an important MHC
goal for people with SMI, and BPR could provide the
much-needed support in achieving this goal.
Strength of BPR is that it focuses on all forms of
meaningful activity and also provides support with more
accessible activities than competitive employment, which
may appeal to a broader group of SMI patients. How-
ever, a potential drawback is that goals could be set too
low and patients achieve less than they are actually cap-
able of.
With this study, we will be the first to gain insight into
effectiveness, cost-effectiveness and budgetary impact of
BPR, which is innovative and will make the study results
of interest and applicable to MHC policy makers and
healthcare funding companies. The findings of our study
could potentially influence routine practice in the care
of people with severe mental illness in the Netherlands
as well as in other countries. The expected findings of
this study will be highly relevant because the study
group consists of a heterogeneous group of outpatients
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with SMI in different MHC settings in different parts of
the Netherlands, adding to the generalisability of the re-
sults. This is important, because BPR is not specific to a
particular diagnosis or group of patients. Also, this study
will have a larger sample size than previous studies in
the area of psychiatric rehabilitation, enabling in-depth
analyses of the cost-effectiveness of BPR.
One of the design’s strengths is the active control
condition, which allows for minimising the influence of
attention by MH professionals and the combination of
subjective and objective/clinical outcome measures.
Also, treatment fidelity is measured throughout the
study period, ensuring close adherence to the BPR
method.
There are also some limitations associated with our
study. In particular, the pragmatic approach to the study
design may be a potential source of bias. For instance,
centres differ in the level of BPR implementation. In
some centres, BPR has been implemented for several
years, whereas in others implementation is in the initial
phase. In centres where BPR is almost fully imple-
mented, the entire working context is modelled accord-
ing to BPR standards. This may also have an effect on
MH professionals in the control group, thus decreasing
the contrast between the experimental and control con-
ditions. On the other hand, contamination between in-
terventions will not readily occur because BPR is too
complex to adopt without proper training and ongoing
supervision and the experimental condition is conducted
by fully trained and experienced BPR workers.
Another limitation is the lack of standardisation of the
control group. MH professionals in the control group
use generic rehabilitation methods based on MH nursing
care, social work and vocational programmes. This
methodological diversity makes it impossible to use a
fidelity measure in the control group. However, this
diversity is in agreement with the reality of daily practice
and workers in the control group will receive regular
supervision to ensure a high quality of care.
We have mentioned the heterogeneity of our group as
an advantage since it promotes generalisability of results.
However, it also has the disadvantage that patients from
FACT teams, regional centres for Residential Care and
those with severe eating disorders in combination with
other psychiatric diagnose, may have different societal
and/or mental health problems and could have different
participation needs. Although stratified randomisation
should ensure an equal distribution in both arms, differ-
ences could impact outcomes for theses subgroups. In
particular, patients with severe eating disorders may have
different goals and need a different kind of support than
other SMI patients. Since rehabilitation has never before
been investigated among these patients, we will initially
analyse this group as a separate pilot and afterwards
perform sensitivity analyses on this group to investigate
if adding this group to our larger sample will influence
outcomes. It should be noted however, that the inclusion
of a group of patients with eating disorders may also in-
crease the relevance of this study because this group has
many needs in rehabilitation areas that deserve atten-
tion, but it has not been investigated before.
Finally, patients are not blinded because this was not
possible in the study design. However, to ensure data in-
tegrity, the interviewers who gather data are blinded and
analyses are only performed on finalised and anonymous
datasets.
If BPR proves to be a cost-effective rehabilitation
method, this may lead to its further dissemination. But
most importantly, it will mean that MH professionals
have an evidence-based method at their disposal to fulfil
the enormous need for support in societal participation
and community integration among patients with SMI.
Endnotes
1Until January 1st 2014, 65 years was the retirement
age in the Netherlands. After this date, retirement age is
gradually being increased to 67 years. In our experience,
older patients usually have different goals in societal
participation – most noticeably, other than obtaining
regular employment. We therefore decided to set the
maximum age at 64.
2Patients with Anorexia Nervosa are often hospitalised
for extreme underweight. These patients are often young
and in order to promote a smooth transition from hospi-
talisation to normal life, rehabilitation is started during
hospitalisation. We therefore decided to include inpa-
tients with Anorexia Nervosa. Inpatients must be in the
last phase of inpatient treatment and the date of dis-
charge must have been set.
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